Current status of histone deacetylase inhibitors in cutaneous T-cell lymphoma-Reference-Cited by-同舟云学术

Current status of histone deacetylase inhibitors in cutaneous T-cell lymphoma

Published:2019-12 Issue:6 Volume:154 Page:
ISSN:0392-0488
Container-title:Giornale Italiano di Dermatologia e Venereologia
language:
Short-container-title:G Ital Dermatol Venereol

Author:

Trager Megan H.,Geskin Larisa J.

Publisher

Edizioni Minerva Medica

Subject

Dermatology

Link

https://www.minervamedica.it/pdf.php?cod=R23Y2019N06A0681

Reference92 articles.

1. HDAC inhibitors for the treatment of cutaneous T-cell lymphomas

2. Geskin LJ. Cutaneous T-Cell Lymphoma (Mycosis Fungoides and SéZary Syndrome). In: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, et al., editors. Williams Hematology. Ninth edition. New York, NY: McGraw-Hill Education; 2015.

3. Incidence of Cutaneous T-Cell Lymphoma in the United States, 1973-2002

4. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study

5. Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunopathogenesis of cutaneous T-cell lymphoma in skin of color patients part 2: Sézary syndrome;Clinical Immunology Communications;2023-12

2. Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T4, M0) Cutaneous T-Cell Lymphoma in the Australian Setting;Value in Health;2022-06

3. Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma;Frontiers in Oncology;2021-06-24

4. Cellular Interactions and Inflammation in the Pathogenesis of Cutaneous T-Cell Lymphoma;Frontiers in Cell and Developmental Biology;2020-09-04